Home /
Role of NGF in OA Pain
Studies have identified a new key player in the transmission of pain associated with osteoarthritis (OA) in people, dogs and cats. In adults, Nerve Growth Factor (NGF) plays a significant role in pain signaling. Click on the link to watch the newly identified mechanism of action of Nerve Growth Factor in OA pain.
Duncan Lascelles, BSc, BVSc, PhD, FRCVS, CertVA, CertSAS, discusses the clinical implications of NGF for osteoarthritis pain.
NGF in Central Sensitization
Duncan Lascelles, BSc, BVSc, PhD, FRCVS, CertVA, CertSAS, discusses the clinical implications of NGF for central sensitization.
Anti-NGF for Control of Pain in Dogs and Cats
Read a paper published in Veterinary Record (January 5, 2019) that reviews the science behind NGF and the potential veterinary treatments based on this novel pathway by Masataka Enomoto, BVSc.
STAY INFORMED
Get notified when new resources are added.
Other Resources
Review Paper on anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats.
The role of Nerve Growth Factor (NGF) in pain associated with osteoarthritis has been under investigation for the last two decades. In Dr. Enomoto’s review paper, the authors review the science behind NGF and the potential development of new pain treatments based on this novel pathway.
Published in the same journal, read the short review of the science behind the prior comprehensive article.
Measuring pain in dogs and cats using structured behavioural observation
Providing insight for veterinarians and pet owners alike, Dr. Reid’s recent review paper highlights the tools available to measure pain in dogs and cats based on behavioural changes.
Webinars
Could Nerve Growth Factor lead to a new era in Pain Management?
- Argentina
- Australia
- Austria
- Belgium
- Bolivia
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Costa Rica
- Croatia
- Czech Republic
- Denmark
- Ecuador
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Liberia
- Lithuania
- Malawi
- Malaysia
- Mauritius
- Mexico
- Morocco
- Mozambique
- Netherlands
- New Zealand
- Nigeria
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Kingdom
- United States
- Uruguay
- Vietnam
- Zambia
- Zimbabwe
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.